PHIO

Phio Pharmaceuticals Corp. is a biotechnology firm based in Marlborough, Massachusetts, focused on developing groundbreaking therapeutics that harness the power of the immune system to combat cancer. Utilizing its proprietary self-delivering RNA interference (RNAi) technology, the company aims to create transformative treatments that enhance efficacy while minimizing adverse effects. With a strong pipeline of innovative product candidates, Phio is well-positioned to play a significant role in the advancing landscape of cancer immunotherapy, underscoring its commitment to pioneering research and development in the biopharmaceutical sector.